Protein Detection and Quantification Market Report 2026

The protein detection and quantification market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growth in proteomics research activities, increasing demand for biomarker discovery, expansion of clinical diagnostic testing, adoption of chromatography and spectroscopy techniques, availability of advanced protein reagents.

The protein detection and quantification market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing use of proteomics in personalized medicine, rising demand for high-throughput diagnostic tools, expansion of biopharmaceutical manufacturing quality control, growing integration of AI in protein analytics, increasing investment in clinical research infrastructure. Major trends in the forecast period include increasing adoption of multiplex protein detection platforms, rising use of mass spectrometry-based quantification, growing integration of automated sample processing, expansion of high-sensitivity detection technologies, enhanced focus on data-driven protein analysis.

The increasing demand for personalized medicine is expected to drive the growth of the protein detection and quantification market in the coming years. Personalized medicine is an approach to healthcare that focuses on tailoring treatments and medical interventions to the specific needs of individual patients. The expansion of personalized medicine is supported by rapid advancements in omics technologies, data integration, genetics, and growing recognition of the importance of patient-specific therapies and preventive strategies. Protein detection and quantification play a vital role in personalized medicine by enabling the identification and measurement of specific proteins that serve as biomarkers for individualized patient care. For example, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, an increase from six approvals in 2022. Therefore, the rising demand for personalized medicine is fueling the growth of the protein detection and quantification market.

Major companies operating in the protein detection and quantification market are prioritizing the development of advanced solutions, such as next-generation mass spectrometry technologies, to improve sensitivity, speed, and the depth of biological analysis. Next-generation mass spectrometry solutions are innovative analytical instruments designed to deliver broader proteome coverage, higher throughput, and enhanced quantitative accuracy, enabling researchers to detect and measure proteins with exceptional precision. For instance, in June 2023, Thermo Fisher Scientific Inc., a US-based life science instrumentation company, launched the Orbitrap Astral mass spectrometer, a pioneering system developed to transform biological research. This platform integrates ultra-high-resolution Orbitrap technology with Astral mass analysis to achieve up to ten times more peptide identifications, allowing faster, deeper, and more accurate protein characterization. Combined with Thermo Fisher’s comprehensive proteomics workflows, including sample preparation, chromatography, and data analysis tools, the system offers a streamlined analytical experience. The Orbitrap Astral accelerates scientific discovery, simplifies complex proteomic workflows, and supports advancements in biomarker discovery, translational research, and precision medicine.

In July 2024, Thermo Fisher Scientific Inc., a US-based life sciences company, acquired Olink Holding AB for approximately US$3.1 billion. Through this acquisition, Thermo Fisher sought to expand its proteomics capabilities, strengthen its life sciences product portfolio, and enhance its expertise in high-throughput protein analysis technologies. Olink Holding AB is a Sweden-based biotechnology company that specializes in providing protein detection and quantification services.

Major companies operating in the protein detection and quantification market are Roche Diagnostics, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare, Agilent Technologies Inc., Illumina Inc., Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Horiba ltd., Bio-Techne Corporation, Promega Corporation, Abcam Plc, Molecular Devices LLC, Olink Proteomics, RayBiotech Life Inc., Bio Scientific Research Laboratories.

North America was the largest region in the protein detection and quantification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein detection and quantification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein detection and quantification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the protein detection and quantification market by increasing costs of imported reagents, antibodies, chromatography systems, mass spectrometers, and analytical instrumentation. Research laboratories and biopharmaceutical companies in North America and Europe are most affected due to dependence on imported high-precision equipment, while Asia-Pacific faces export-related pricing pressure. These tariffs are increasing operational expenses and affecting technology adoption rates. However, they are also encouraging regional manufacturing of reagents, domestic assembly of instruments, and strengthening local analytical service ecosystems.

The protein detection and quantification market research report is one of a series of new reports that provides protein detection and quantification market statistics, including protein detection and quantification industry global market size, regional shares, competitors with a protein detection and quantification market share, detailed protein detection and quantification market segments, market trends and opportunities, and any further data you may need to thrive in the protein detection and quantification industry. This protein detection and quantification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein detection and quantification refers to the identification and measurement of proteins present in biological samples using a range of techniques and analytical assays. These processes are fundamental to research, diagnostics, and industrial applications, supporting activities such as biomarker identification, drug discovery and development, clinical diagnostics, proteomics research, biomanufacturing quality control, and personalized medicine.

The key products in the protein detection and quantification market include kits and reagents or consumables, instruments, and services. Kits and reagents are critical components used in protein detection and measurement assays, consisting of specialized substances that interact with proteins to enable accurate detection and quantification. These kits generally contain antibodies, enzymes, substrates, and buffers required for specific protein assays. The technologies involved include colorimetric assays, immunological methods, chromatography, mass spectrometry, spectroscopy instruments, and other techniques. These solutions are applied across areas such as drug discovery and development, clinical diagnostics, and other applications, and are used by end users including academic research institutes, biotechnology and pharmaceutical companies, contract research organizations, and others.

The protein detection and quantification market consists revenues earned by entities by providing services such as protein profiling, protein quantification, clinical testing services, and assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein detection and quantification market also includes sales of western blotting reagents and kits, protein quantification assays, mass spectrometry consumables, protein purification kits, and automated protein analysis systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.